Brief: Avalo Reports Third Quarter Financial Results

Avalo Therapeutics

07/11/2022 14:36

Nov 7 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND PROVIDES
BUSINESS UPDATES
    * AVALO THERAPEUTICS INC- TOPLINE DATA EXPECTED IN FIRST
HALF OF
2023 FROM PHASE 2 PEAK TRIAL OF AVTX-002 IN NON-EOSINOPHILIC
ASTHMA (NEA)
    * AVALO THERAPEUTICS INC- QTRLY EPS $0.34

Source text for Eikon:  ID:nGNX5KWLPR 
Further company coverage:  AVTX.O 
 ((reuters.briefs@thomsonreuters.com;))